Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pruneri

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 3, 2009
Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study GroupG Martinelli, G Ryan, J F Seymour, et al.
British Journal of Cancer|April 13, 2013
Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotypeM Lazzeroni, A Guerrieri-Gonzaga, E Botteri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2017
A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancerC Criscitiello, M A Bayar, G Curigliano, et al.
ESMO Open|March 9, 2024
Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysisG Nader-Marta, M Monteforte, E Agostinetto, et al.
Breast Cancer Research and Treatment|April 1, 2011
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypesG Cancello, P Maisonneuve, N Rotmensz, et al.
Histopathology|April 21, 2006
The prevalence and clinical implications of c-kit expression in plasma cell myelomaG Pruneri, M Ponzoni, A J M Ferreri, et al.
Journal of Cancer Research and Clinical Oncology|April 9, 2022
Early stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNAE La Rocca, M C De Santis, M Silvestri, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 9, 2025
Reliability of core needle biopsy for HER2-low early-stage breast cancerC M Ciniselli, P Verderio, V Duroni, et al.
Breast Cancer Research and Treatment|April 30, 2024
Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTOS Pizzamiglio, C M Ciniselli, E de Azambuja, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2013
Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort studyA Guerrieri-Gonzaga, M Lazzeroni, E Botteri, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 3, 2009
Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study GroupG Martinelli, G Ryan, J F Seymour, et al.
British Journal of Cancer|April 13, 2013
Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotypeM Lazzeroni, A Guerrieri-Gonzaga, E Botteri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2017
A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancerC Criscitiello, M A Bayar, G Curigliano, et al.
ESMO Open|March 9, 2024
Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysisG Nader-Marta, M Monteforte, E Agostinetto, et al.
Breast Cancer Research and Treatment|April 1, 2011
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypesG Cancello, P Maisonneuve, N Rotmensz, et al.
Histopathology|April 21, 2006
The prevalence and clinical implications of c-kit expression in plasma cell myelomaG Pruneri, M Ponzoni, A J M Ferreri, et al.
Journal of Cancer Research and Clinical Oncology|April 9, 2022
Early stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNAE La Rocca, M C De Santis, M Silvestri, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 9, 2025
Reliability of core needle biopsy for HER2-low early-stage breast cancerC M Ciniselli, P Verderio, V Duroni, et al.
Breast Cancer Research and Treatment|April 30, 2024
Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTOS Pizzamiglio, C M Ciniselli, E de Azambuja, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2013
Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort studyA Guerrieri-Gonzaga, M Lazzeroni, E Botteri, et al.
Pageof 11